June 6, 2019 07:25 PM EDTUpdated June 7, 04:23 PM
People

Sanofi re­cruits No­var­tis' top phar­ma ex­ec Paul Hud­son as its new CEO — so what hap­pens now?

John Carroll

Editor & Founder

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Have sky-high sales pro­jec­tions set the obe­si­ty mar­ket up to fail?

Vaxart shares surge on norovirus vac­cine da­ta as it seeks fund­ing for new tri­als

Trump’s HHS urges against re­viv­ing Cham­ber of Com­merce’s IRA law­suit

Trump of­fi­cials seek price de­tails and weigh con­sumer sales as they ex­am­ine most fa­vored na­tion plan

Up­dat­ed: Mer­ck wins FDA ap­proval for RSV an­ti­body drug, mak­ing a hot mar­ket more com­pet­i­tive

sponsored

McKesson leads the charge in rev­o­lu­tion­iz­ing pre­ci­sion on­col­o­gy in com­mu­ni­ty prac­tices

A service from the Financial Times